Return to Listing

1 result(s) for

PI Name Protocol # Title
Charles Lopez STUDY00020901 A Phase 2/3 Trial to Evaluate Margetuximab in Combination with INCMGA00012 and Chemotherapy or MGD013 and Chemotherapy in Patients with Metastatic or Locally Advanced, Treatment-naïve, HER2-Positive Gastric or Gastroesophageal Junction Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080